MBX Biosciences, Inc. Common Stock
MBX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $598 | $382 | $247 | $615 |
| - Cash | $223 | $40 | $30 | $49 |
| + Debt | $1 | $1 | $0 | $0 |
| Enterprise Value | $376 | $342 | $217 | $566 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$22 | -$22 | -$26 | -$19 |
| % Margin | – | – | – | – |
| Net Income | -$22 | -$19 | -$24 | -$16 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.63 | -0.58 | -0.71 | -0.47 |
| % Growth | -8.6% | 18.3% | -51.1% | – |
| Operating Cash Flow | -$22 | -$17 | -$23 | -$16 |
| Capital Expenditures | -$0 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$22 | -$18 | -$23 | -$16 |